Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current and ongoing randomized trials in heart failure and left ventricular dysfunction

R Garg1, S Yusuf

  • 1Clinical Trials Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892.

Journal of the American College of Cardiology
|October 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Search for B→X_{s}νν[over ¯] Decays.

Physical review letters·2026
Same author

Search for Feebly Interacting Particles in B Decays with Missing Energy at Belle.

Physical review letters·2026
Same author

Phase I Clinical Study of DOC1021 (dubodencel) for Adjuvant Immunotherapy of Glioblastoma.

medRxiv : the preprint server for health sciences·2026
Same author

Constraining the Synthesis of the Lightest p Nucleus ^{74}Se.

Physical review letters·2025
Same author

Search for B^{0}→K^{*0}τ^{+}τ^{-} Decays at the Belle II Experiment.

Physical review letters·2025
Same author

Search for a Dark Higgs Boson Produced in Association with Inelastic Dark Matter at the Belle II Experiment.

Physical review letters·2025
Same journal

Aortic Valve Replacement in Women of Reproductive Age.

Journal of the American College of Cardiology·2026
Same journal

Sudden Death in Cardio-Kidney-Metabolic Patients: Insights From FINE-HEART.

Journal of the American College of Cardiology·2026
Same journal

Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Diabetic Multivessel Coronary Artery Disease Patients: The TUXEDO-2 Trial.

Journal of the American College of Cardiology·2026
Same journal

Reframing Cardiometabolic Risk and Frailty Through Sarcopenic Obesity.

Journal of the American College of Cardiology·2026
Same journal

Imaging-Derived Sarcopenic Obesity and Cardiovascular Outcomes: Insights Into Heart Failure Risk and Muscle Biology.

Journal of the American College of Cardiology·2026
Same journal

The Measure of a Leader: Lessons in Leadership From Eugene Braunwald.

Journal of the American College of Cardiology·2026
See all related articles

Recent heart failure trials offer valuable insights into treatments for left ventricular dysfunction. Future clinical trials are essential to address remaining questions and further advance patient care.

Area of Science:

  • Cardiology
  • Clinical Trials
  • Heart Failure Research

Background:

  • Numerous large randomized trials have recently concluded, yielding significant data on interventions for heart failure and left ventricular dysfunction.
  • A comprehensive review identified 19 major ongoing trials investigating the impact of various treatments on exercise tolerance, morbidity, and mortality.

Purpose of the Study:

  • To summarize the current landscape of randomized trials in heart failure.
  • To highlight the ongoing research efforts and the anticipated generation of new questions.

Main Methods:

  • Review of recently completed large randomized trials.
  • Analysis of ongoing randomized clinical trials in the field of heart failure.

Main Results:

Related Experiment Videos

  • Completed trials have provided substantial information on heart failure interventions.
  • 19 major ongoing trials are actively investigating treatment effects on key clinical outcomes.

Conclusions:

  • While current and ongoing trials will answer many questions, they are also expected to generate new research inquiries.
  • Future clinical trials will be crucial for addressing the remaining knowledge gaps in heart failure management.